Faster Blood Processing Could Improve Gestational Diabetes Diagnosis During Pregnancy
A study found that faster blood processing could double the detection of gestational diabetes, reducing complications for mothers and babies.
Category: Prenatal Testing
Prenatal Testing
Latest
Prenatal Testing
Latest
Yourgene Health Launches Automated DNA Extraction Instrument for NIPT Workflows
MagBench offers a bench-top robotic cell-free DNA (cfDNA) extraction workstation optimized for Yourgene’s Sage 32 NIPT Workflow.
Prenatal Testing
Latest
Biomarkers Could Point to Preclampsia Risk
Cedars-Sinai investigators have found that a specific imbalance of two placental proteins could predict preeclampsia risk.
Prenatal Test Developed for At-Risk Pregnancies
Veritas has created a new prenatal diagnostic test that can help identify fetal anomalies in at-risk pregnancies.
Read More
Biomarkers Id’d that May Detect Pregnancy Risks Earlier
Researchers have identified biological markers that could improve blood tests of pregnant women to detect risks of pregnancy complications earlier.
Read More
BioFluidica to Commericalize LiquidScan Biopsy System
BioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.Â
Read More
Portfolio of Reproductive Information-Driven Genomic Solutions Introduced
Sema4 Elements, a portfolio of information-driven genomic reproductive health solutions that enable providers to treat patients holistically, has launched.
Read More
Many Pregnant Women Don’t Get Blood Test to Check Iron Levels
Half of pregnant women who had a simple blood test to check their iron stores had low iron levels; one in four had severe iron deficiency.
Read More
BioReference Laboratories Acquires Prenatal Testing Business from Roche
BioReference Laboratories, Inc. has acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche.
Read More
EchelonDx, Cradle Genomics Join Forces on Non-Invasive Prenatal Diagnostic Products
As part of the agreement, EchelonDx is providing expertise using its precise PrenatalDx technology to help enhance the data analysis and reporting capabilities for Cradle’s comprehensive fetal genetic analysis and health screening solutions.
Read More
Real-World Evidence Shows Cost Effectiveness of Offering NIPT to All Pregnant Women
Offering insurance coverage of non-invasive prenatal testing to all pregnant women increases utlilization at a cost of less than 3 cents per member per month.
Read More
Scientists Develop Blood Test to Predict Environmental Harms to Children
The method uses a DNA biomarker to easily screen pregnant women for harmful prenatal environmental contaminants like air pollution linked to childhood illness and developmental disorders.
Read More
Sera Prognostics PreTRM Blood Test Gets CPT PLA Code
The new CPT PLA code will facilitate billing and payment for the PreTRM Test, the company’s proprietary proteomic blood test for measuring a woman’s risk of spontaneous preterm birth to enable timely intervention.
Read More
Sera Prognostics, Anthem Launch Study to Improve Outcomes for Preterm Babies
The PRIME study is designed to provide a blueprint for how healthcare can more effectively identify and manage high-risk pregnancies and reduce preterm birth.
Read More
Protein Linked to Gestational Diabetes
A new study outlines a role for pregnancy-associated plasma protein A in gestational diabetes, with potential as a diagnostic tool and therapeutic target.
Read More
Progenity Test for Triaging Preeclampsia Passes Key Development Milestone
This proprietary test is a multi-analyte protein biomarker assay which is designed to be run from a simple blood draw.
Read More
Study: Enhanced Common Blood Test Could Predict Adverse Outcomes in Pregnancy
A blood test commonly used to detect fetal genetic abnormalities can be modified to help predict complications associated with pregnancy before any symptoms develop, according to UCLA researchers and colleagues.
Read More
Myriad’s Amplify Technology Improves Prequel NIPS Test
The Amplify process increases the fetal fraction of a NIPS sample by preferentially sequencing the fetal cell-free DNA fragments that circulate in a mother’s blood.
Read More